RPRX
$57.16-0.82%
as of close, Oct 2, 2026
☾ AH $57.16 -0.82%
Royalty Pharma plcStock · Health CareNasdaq Composite 0.05%Russell 1000 0.03%Russell 3000 0.03%MSCI World 0.02%MSCI ACWI 0.02%
RPRX financial statements
The full income statement, balance sheet, and cash-flow statement for Royalty Pharma plc (RPRX), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.
Shares outstanding (point-in-time)
2024-06 593.5M2024-09 589.2M2024-12 576.5M2025-03 562.2M2025-06 583.2M2025-09 577.2M2025-12 576.9M2026-03 575.8M2026-06 575.0M-3.1% over 8 periods
SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.
As-reported fiscal years.
| Line item | Trend | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Income Statement | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Revenue | 2.38B+5.1% | 2.26B-3.9% | 2.35B+5.2% | 2.24B-2.3% | 2.29B+7.9% | |
| Research & development | 452M+22500.0% | 2.00M-96.2% | 52.0M-70.6% | 177M-11.5% | 200M+661.1% | |
| Selling, general & administrative | 573M+142.3% | 237M-5.2% | 250M+9.9% | 227M+24.3% | 183M+0.6% | |
| General & administrative | 573M+142.3% | 237M-5.2% | 250M+9.9% | 227M+24.3% | 183M+0.6% | |
| Amortization of intangibles | — | 0.00 | 0.00-100.0% | 5.67M-75.3% | 23.0M-0.3% | |
| Provision for credit losses | — | — | — | — | 453M+96.2% | |
| Operating income | 1.56B+20.7% | 1.29B-13.4% | 1.49B+385.9% | 307M-78.5% | 1.43B-10.3% | |
| Interest expense | 308M+36.4% | 226M+20.5% | 187M-0.4% | 188M+13.1% | 166M+5.8% | |
| Other non-operating income | -14.3M-839.1% | -1.53M+93.0% | -21.7M-47.3% | -14.8M-159.9% | -5.68M+82.7% | |
| Equity-method income | 29.1M-1.8% | 29.6M+2.5% | 28.9M+421.9% | -8.97M+54.0% | -19.5M-143.8% | |
| Gain (loss) on equity securities | -21.9M-155.3% | 39.5M-54.6% | 87.1M+360.6% | -33.4M+30.4% | -48.1M-119.5% | |
| Pre-tax income | 1.32B-0.5% | 1.33B-21.7% | 1.70B+639.0% | 230M-81.5% | 1.24B-27.1% | |
| Income tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| 771M-10.2% | 859M-24.3% | 1.13B+2549.5% | 42.8M-93.1% | 620M-36.4% | ||
| Net income to non-controlling interest | 553M+17.3% | 472M-16.5% | 565M+201.9% | 187M-69.9% | 621M-14.5% | |
| Net income to common | 771M-10.2% | 859M-24.3% | 1.13B+2549.5% | 42.8M-93.1% | 620M+25.1% | |
| $1.78-6.8% | $1.91-24.5% | $2.53+2430.0% | $0.10-93.3% | $1.49+12.9% | ||
| EPS (basic) | $1.79-6.8% | $1.92-24.4% | $2.54+2440.0% | $0.10-93.3% | $1.49+12.9% | |
| Weighted-avg shares (basic) | 430M-4.1% | 448M+0.1% | 448M+2.2% | 438M+5.6% | 415M+10.5% | |
| Weighted-avg shares (diluted) | 564M-5.0% | 594M-1.5% | 603M+37.7% | 438M+5.6% | 415M+10.5% | |
| Dividends per share | — | $0.84+5.0% | $0.80+5.3% | $0.76+11.8% | $0.68+126.7% | |
| Balance Sheet | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| 1.53B-15.2% | 1.80B+41.4% | 1.27B-50.1% | 2.55B-11.2% | 2.88B+6.7% | ||
| Cash & equivalents | 619M-33.4% | 929M+94.8% | 477M-72.1% | 1.71B+11.0% | 1.54B+52.8% | |
| Other current assets | 6.89M+64.6% | 4.19M-76.8% | 18.0M-80.1% | 90.5M+1265.1% | 6.63M-22.9% | |
| 19.6B+7.7% | 18.2B+11.2% | 16.4B-2.6% | 16.8B-4.0% | 17.5B+9.3% | ||
| Goodwill | 925M | 0.00 | — | — | — | |
| Intangible assets | — | — | — | 0.00-100.0% | 5.67M-80.2% | |
| Other non-current assets | 79.3M+136.5% | 33.5M+414.2% | 6.52M-78.0% | 29.6M+614.8% | 4.14M-58.5% | |
| 636M-49.2% | 1.25B+676.8% | 161M-86.2% | 1.17B+581.3% | 171M-44.4% | ||
| Accrued liabilities | 19.4M+45.1% | 13.4M-11.8% | 15.2M+91.8% | 7.91M+40.7% | 5.62M-47.8% | |
| Short-term & current debt | 380M-61.9% | 998M | 0.00-100.0% | 998M | 0.00 | |
| Other current liabilities | 53.2M-22.5% | 68.6M+503.1% | 11.4M-8.3% | 12.4M | 0.00-100.0% | |
| 9.91B+25.7% | 7.88B+25.1% | 6.30B-13.6% | 7.29B+0.3% | 7.27B+18.7% | ||
| Long-term debt | 8.57B+29.6% | 6.61B+7.8% | 6.14B+0.3% | 6.12B-13.8% | 7.10B+22.0% | |
| Operating lease liability (total) | 19.3M | — | — | — | — | |
| Other non-current liabilities | 121M+900.4% | 12.1M+1242.2% | 900K-64.0% | 2.50M | 0.00 | |
| 9.71B-6.1% | 10.3B+2.6% | 10.1B+5.9% | 9.53B-7.1% | 10.2B+3.6% | ||
| Additional paid-in capital | 4.12B+0.5% | 4.10B+2.3% | 4.01B+9.4% | 3.67B+4.5% | 3.51B+22.4% | |
| Retained earnings | 2.36B-17.2% | 2.85B+13.0% | 2.52B+28.1% | 1.96B-12.9% | 2.26B+17.4% | |
| Treasury stock | 2.61M-1.9% | 2.66M+1.3% | 2.63M-6.3% | 2.81M+3.4% | 2.71M+17.2% | |
| Accumulated other comprehensive income | — | — | — | 0.00-100.0% | 16.5M-52.1% | |
| Non-controlling interest | 3.24B-4.6% | 3.40B-4.6% | 3.56B-8.7% | 3.90B-12.9% | 4.47B-11.9% | |
| Total equity incl. non-controlling | 9.71B-6.1% | 10.3B+2.6% | 10.1B+5.9% | 9.53B-7.1% | 10.2B+3.6% | |
| Total liabilities & equity | 19.6B+7.7% | 18.2B+11.2% | 16.4B-2.6% | 16.8B-4.0% | 17.5B+9.3% | |
| Cash Flow | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| 2.49B-10.1% | 2.77B-7.3% | 2.99B+39.4% | 2.14B+6.3% | 2.02B-0.8% | ||
| Depreciation & amortization | 3.85M | 0.00 | 0.00 | — | — | |
| Intangible amortization | — | 0.00 | 0.00-100.0% | 5.67M-75.3% | 23.0M-0.3% | |
| Share-based compensation | 290M+12267.5% | 2.34M-0.6% | 2.36M+8.6% | 2.17M-11.2% | 2.44M-55.0% | |
| -1.61B+39.7% | -2.68B-29.2% | -2.07B-101.4% | -1.03B+45.0% | -1.87B+32.2% | ||
| Acquisitions | 74.4M | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other investing activities | 8.95M+538.7% | -2.04M-200.0% | 2.04M | 0.00 | 0.00 | |
| -1.19B-428.4% | 361M+116.8% | -2.15B-127.4% | -945M-345.3% | 385M-74.1% | ||
| Long-term debt issued | 0.00 | 0.00 | 0.00 | 0.00-100.0% | 1.27B-89.3% | |
| Long-term debt repaid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00-100.0% | |
| Common stock issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Common stock repurchased | 1.23B+434.5% | 230M-24.6% | 305M | 0.00 | 0.00 | |
| Dividends paid | 0.00 | — | — | — | — | |
| Other financing activities | -1.79M+80.2% | -9.03M | 0.00 | 0.00 | — | |
| Net change in cash | -310M-168.7% | 452M+136.6% | -1.23B-827.0% | 170M-68.1% | 532M-30.2% | |
| Interest paid | 276M+73.1% | 160M-5.7% | 169M-0.6% | 170M+30.4% | 130M+26.4% | |
| Valuation Ratios | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Market cap | 22.3B+51.6% | 14.7B-12.4% | 16.8B-30.1% | 24.0B-0.8% | 24.2B-20.4% | |
| P/E | 28.9×+68.9% | 17.1×-81.2% | 91.0×+92.2% | 47.3×+21.3% | 39.0×+25.3% | |
| P/S | 9.4×+44.3% | 6.5×-10.0% | 7.2×-32.4% | 10.7×+1.0% | 10.6×-26.2% | |
| P/B | 2.3×+61.4% | 1.4×-18.8% | 1.8×-24.0% | 2.3×-2.4% | 2.4×-23.1% | |
| Earnings yield | 3.5%-40.8% | 5.8%+431.6% | 1.1%-48.0% | 2.1%-17.5% | 2.6%-20.2% | |
| Dividend yield | — | 3.3%+15.6% | 2.8%+48.1% | 1.9%+12.7% | 1.7%+184.7% | |
| Source filing | 10-K | 10-K | 10-K | 10-K | 10-K |
About this data
Source: RPRX’s SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn’t file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all RPRX filings on SEC EDGAR → Not investment advice.